Mono Pharmacare Limited (NSE:MONOPHARMA)

Market Cap	429.35M
Revenue (ttm)	1.69B
Net Income (ttm)	30.90M
Shares Out	17.67M
EPS (ttm)	1.75
PE Ratio	13.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Average Volume	26,800
Open	24.50
Previous Close	25.55
Day's Range	24.30 - 24.50
52-Week Range	22.10 - 41.95
Beta	n/a
RSI	46.85
Earnings Date	n/a

About Mono Pharmacare

Mono Pharmacare Limited engages in the marketing and distribution of pharmaceutical products in India. The company offers products in various categories, such as antibiotics, anti-fungal, anti cough- cold and anti-allergic, antacid and antiemetics, analgesic and antipyretic, nutraceuticals, skin care, antiseptic, cardiac and diabetics, cosmetics, etc. It also sells its pharmaceutical products under the DLS Export brand name. The company was founded in 1994 and is based in Ahmedabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MONOPHARMA

Financial Performance

In 2024, Mono Pharmacare's revenue was 1.69 billion, an increase of 38.30% compared to the previous year's 1.22 billion. Earnings were 30.90 million, an increase of 26.52%.